D-1553
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for D-1553, covering 2024-04-26 to 2026-03-25. Get the full timeline:
Most recent: Clinical Trial Update: a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors [Phase 1, Phase 2]